Sapience Therapeutics sapiencetherapeutics.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

Sapience Therapeutics is a preclinical-stage biotechnology company focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. The company's drug development program involves translating science into novel therapies, and its initial goal is to develop a treatment for glioblastoma multiforme (GBM).

Sapience Therapeutics is a preclinical-stage biotechnology company focuses on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. The company's drug development program involves translating science into no...Show all

Company (Alive / Active)

Phone: 914-607-6931

Fax:

500 Mamaroneck Ave
Suite 320
Harrison, 10528
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sapience Therapeutics $36.8M Jul 13, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sapience Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
CelgeneCorporationSummit, New Jersey, United StatesSeries A
Bristol-Myers SquibbCorporationNew York, New York, United StatesUnattributed
Eshelman VenturesVenture CapitalWilmington, North Carolina, United StatesSeries A
Columbia UniversityAcademic/UniversityNew York, New York, United StatesSeries A
Healthlink CapitalOtherSeries A
See all 7 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Atf5 peptide variants and uses thereof Jan 03, 2019 Jan 07, 2020 Patent
Cell-penetrating atf5 polypeptides and uses thereof Feb 17, 2018 Jun 11, 2019 Patent